Insulin allergy

Clinics in Dermatology

Volumn 29, Issue 3, 2011, Pages 300-305

  Ghazavi, Mohammad K ^a   Johnston, Graham A ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; APIDRA OPTISET; B INSULIN S; BERLINSULIN H; BERLINSULIN H NORMAL; CRESOL; EPOXY RESIN; HUMINSULIN BASAL; HUMINSULIN BASAL FOR PEN; HUMINSULIN PROFIL; INSULIN; INSULIN ASPART; INSULIN B BRAUN; INSULIN B BRAUN BASAL; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; INSULIN NOVO SEMILENTE MC; INSULIN S BERLIN CHEMIE; INSULIN SNC BERLIN CHEMIE; INSULIN ZINC SUSPENSION; ISOPHANE INSULIN; NEUTRAL INSULIN; PROTAMINE; RECOMBINANT HUMAN INSULIN; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ARTICLE; DELAYED HYPERSENSITIVITY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DRUG DOSE INCREASE; DRUG TOLERABILITY; DYSPNEA; HUMAN; HYPOTENSION; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOTHERAPY; INSULIN ALLERGY; INSULIN DEPENDENT DIABETES MELLITUS; PATCH TEST; PREVALENCE; PRICK TEST; PRIORITY JOURNAL; SKIN BIOPSY; TYPE 3 HYPERSENSITIVITY; TYPE 4 HYPERSENSITIVITY;

ANIMALS; CATTLE; DRUG HYPERSENSITIVITY; HUMANS; HYPERSENSITIVITY, DELAYED; HYPERSENSITIVITY, IMMEDIATE; HYPOGLYCEMIC AGENTS; IMMUNOGLOBULIN E; INSULIN; PRESERVATIVES, PHARMACEUTICAL; SWINE;

EID: 79954564354     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2010.11.009     Document Type: Article

References (44)

1. Bliss M. The discovery of insulin 1982, 155. University of Chicago Press, Chicago.
2. Jersild M. Insulin zinc suspension; four years' experience. Lancet 1956, 271:1009-1013.
3. Schernthaner G. Immunogenicity and allergenic potential of animal and human insulins. Diabetes Care 1993, 16(suppl 3):155-165.
4. Katsoyannis P.G., Tometsko A., Zalut C., Insulin peptides X.I.I. Human insulin generation by combination of synthetic A and B chains. J Am Chem Soc 1966, 88:186.
5. Matheu V. Et al. Insulin allergy and resistance successfully treated by desensitisation with Aspart insulin. Clin Molec Allergy 2005, 3:16.
6. Plantin P., Sassolas B., Guillet M.H. Accident cutanes allergiques aux insulines. Ann Dermatol Venereol 1988, 115:813-817.
7. Heinzerling L., Raile K., Rochlitz H., Zuberbier T., Worm M. Insulin allergy. Allergy 2008, 63:148-155.
8. Chng H.H., Leong K.P., Loh K.C. Primary systemic allergy to human insulin. Allergy 1995, 50:984-987.
9. Gonzalo M.A., de Argila D., Revenga F., Garcia J.M., Diaz J., Morales F. Cutaneous allergy to human insulin. Allergy 1998, 53:106-107.
10. Blanco C Castillo R., Quiralte J., et al. Anaphylaxis to subcutaneous neutral protamine Hagedorn insulin with simultaneous sensitization to protamine and insulin. Allergy 1996, 51:421-424.
11. Scheer B.G., Sitz K.V. Suspected insulin anaphylaxis and literature review. J Ark Med Soc 2001, 97:311-313.
12. Lee A.Y., Chey W.Y., Choi J., Jeon J.S. Insulin induced drug eruptions and reliability of skin tests. Acta Derm Venereol 2002, 82:114-117.
13. Rajpar S.F., Foulds I.S., Abdullah A., Maheshwari M. Severe adverse cutaneous reaction to insulin due to cresol sensitivity. Contact Dermatitis 2006, 55:119-120.
14. Eapen S.S., Connor E.L., Gern J.E. Insulin desensitization with insulin lispro and an insulin pump in a 5 year old child. Ann Allergy Asthma Immunol 2000, 85:395-397.
15. Moyes V., Driver R., Croom A., Mirakian R., Chowdhury T.A. Insulin allergy in a patient with Type 2 diabetes successfully treated with continuous subcutaneous insulin infusion. Diabet Med 2006, 23:204-206.
16. Naf S., Esmatjes E., Recasens M., et al. Continuous subcutaneous insulin infusion to resolve an allergy to human insulin. Diabetes Care 2002, 25:634-635.
17. Nagai T., Nagai Y., Tomizawa T., Mori M. Immediate type human insulin allergy successfully treated by continuous subcutaneous insulin infusion. Intern Med 1997, 36:575-578.
18. Radermecker R.P., Scheen A.J. Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues. Diabetes Metab Res Rev 2007, 23:348-355.
19. Yokoyama H., Fukumoto S., Koyama H., Emoto M., Kitagawa Y., Nishizawa Y. Insulin allergy; desensitization with crystalline zinc insulin and steroid tapering. Diabetes Res Clin Pract 2003, 61:161-166.
20. Asai M., Yoshida M., Miura Y. Immunologic tolerance to intravenously injected insulin. N Engl J Med 2006, 354:307-309.
21. Silva M.E., Mendes M.J., Ursich M.J., et al. Human insulin allergy-immediate and late Type III reactions in a long-standing IDDM patient. Diabetes Res Clin Pract 1997, 36:67-70.
22. Darmon P., Castera V., Koeppel M.C., Petitjean C., Dutour A. Type 3 allergy to insulin detemir. Diabetes Care 2005, 28:2980.
23. Williams NH, Whitten WM Orchid floral fragrances and male euglossine bees: methods and advances in the last sesquidecade. Biol Bull 1983, 164:355-395.
24. Clerx V., Keybus V.D., Kochuyt A., Goossens A. Drug intolerance reaction to insulin therapy caused by metacresol. Contact Dermatitis 2003, 48:162-163.
25. Kim D., Baraniuk J. Delayed-type hypersensitivity reaction to the meta-cresol component of insulin. Ann Allergy Asthma Immunol 2007, 99:194-195.
26. May C.A. Epoxy resins: chemistry and technology 1987, 794. Marcel Dekker Inc, New York. 2nd ed.
27. Cronin E. Contact dermatitis 1980, 595-614. Churchill Livingstone, London.
28. Fisher A.A. Contact dermatitis 1986, 546-554. Lea and Febiger, Philadelphia. 3rd ed.
29. Boom B.W., Van Dariel L.M. Allergic contact dermatitis to epoxy resin in infusion sets of an insulin pump. Contact Dermatitis 1985, 12:280.
30. Geldof B.A., Oranje A.P., Joost V. Hand eczema associated with continuous subcutaneous insulin infusion. Contact Dermatitis 1989, 20:384-385.
31. Porsche R., Brenner Z.R. Allergy to protamine sulphate. Heart Lung 1999, 28:418-428.
32. Kahn C.R., Rosenthal A.S. Immunologic reaction to insulin. Diabetic Care 1979, 2:283-295.
33. Ratner R.E., Phillips T.M., Steiner M. Persistent cutaneous insulin allergy resulting from high molecular weight insulin aggregates. Diabetes 1990, 39:728-733.
34. Yip C.M., Brader M.L., DeFellipis M.R., Ward M.D. Atomic force microscopy of crystalline insulins. Biophys J 1998, 74:2199-2209.
35. Simpson K., Clements M., Ogilvie A., et al. A case of insulin allergy: something to zinc about. Endocrine Abstracts 2008, 18:36.
36. Shepherd G.M. Hypersensitivity reaction to drugs: evaluation an management. Mt Sinai J Med 2003, 70:113-125.
37. Mishra D.K., Sathyamurthy I., Subramanyan K., Girinath M.R. Life threatening protamine reaction during bypass surgery-a case report. Indian Heart J 2009, 61:216-217.
38. Chang L.C., Liang J.F., Lee H.F., Lee L.M., Yang V.C. Low molecular weight protamine (LMWP) as nontoxic heparin/low molecular weight heparin antidote (II): in vitro evaluation of efficacy and toxicity. AAPS PharmSci 2001, 3. article 18.
39. Bodtger U., Wittrup M. A rational clinical approach to suspected insulin allergy: status after five years and 22 cases. Diabet Med 2005, 22:102-106.
40. Velcovsky H.G., Federlin K.F. Insulin specific IgG and IgE antibody response to type one diabetic subjects exclusively treated with human insulin. Diabetes Care 1982, 5:126-128.
41. Jegasothy B.V. Allergic reactions to insulin. Int J Dermatol 1980, 19:139-141.
42. Danne T., Niggemann B., Weber B., Wahn U. Prevalence of latex specific IgE antibodies in atopic and nonatopic children with type I diabetes. Diabetes Care 1997, 20:476-478.
43. Roest M.A., Shaw S., Orton D.I. Insulin injection site reactions associated with type I latex allergy. N Engl J Med 2003, 348:265-266.
44. deShazo R.D., Boehm T.M., Kumar D., Galloway J.A., Dvorak H.F. Dermal hypersensitivity reactions to insulin: correlation of three patterns to their histopathology. J Allergy Clin Immunol 1982, 69:229-237.